Search Results

There are 731 results for: content related to: Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke

  1. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  2. Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1354–1373, Dr. Brooke E. Baetz and Dr. Sarah A. Spinler

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1354

  3. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

    Journal of the American Association of Nurse Practitioners

    Volume 27, Issue 4, April 2015, Pages: 190–196, Katie A. Scott and Karen A. Amirehsani

    Version of Record online : 25 JUL 2014, DOI: 10.1002/2327-6924.12161

  4. You have free access to this content
    A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  5. You have free access to this content
    Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

    British Journal of Clinical Pharmacology

    Volume 74, Issue 3, September 2012, Pages: 490–500, Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer and Paul A. Reilly

    Version of Record online : 6 AUG 2012, DOI: 10.1111/j.1365-2125.2012.04218.x

  6. You have free access to this content
    Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

    Arthritis & Rheumatism

    Volume 63, Issue 5, May 2011, Pages: 1416–1425, Galina S. Bogatkevich, Anna Ludwicka-Bradley, Paul J. Nietert, Tanjina Akter, Joanne van Ryn and Richard M. Silver

    Version of Record online : 27 APR 2011, DOI: 10.1002/art.30255

  7. New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 8, August 2011, Pages: 948–955, JUAN F. VILES-GONZALEZ, VALENTIN FUSTER and JONATHAN L. HALPERIN

    Version of Record online : 10 JUN 2011, DOI: 10.1111/j.1540-8167.2011.02104.x

  8. Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 555–565, Dr Joachim Stangier, Dr Bengt I. Eriksson, Dr Ola E. Dahl, Dr Lennart Ahnfelt, Dr Gerhard Nehmiz, Hildegard Stähle, Dr Karin Rathgen and Dr Robbyna Svärd

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005274550

  9. You have free access to this content
    Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 9, September 2004, Pages: 1573–1580, B. I. Eriksson, O. E. Dahl, L. Ahnfelt, P. Kälebo, J. Stangier, G. Nehmiz, K. Hermansson and V. Kohlbrenner

    Version of Record online : 10 AUG 2004, DOI: 10.1111/j.1538-7836.2004.00890.x

  10. Rash Associated with Dabigatran Etexilate

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 3, March 2013, Pages: e23–e27, Kim To, Carl Reynolds and Sarah A. Spinler

    Version of Record online : 11 FEB 2013, DOI: 10.1002/phar.1203

  11. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  12. You have free access to this content
    Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital

    Internal Medicine Journal

    Volume 43, Issue 7, July 2013, Pages: 778–783, P. K. L. Chin, J. W. A. Vella-Brincat, S. L. Walker, M. L. Barclay and E. J. Begg

    Version of Record online : 11 JUL 2013, DOI: 10.1111/imj.12170

  13. You have free access to this content
    Direct thrombin inhibitors

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 581–592, Catherine J. Lee and Jack E. Ansell

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.03916.x

  14. You have free access to this content
    The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

    British Journal of Clinical Pharmacology

    Volume 64, Issue 3, September 2007, Pages: 292–303, Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Gansser and Willy Roth

    Version of Record online : 15 MAY 2007, DOI: 10.1111/j.1365-2125.2007.02899.x

  15. Hemopericardium in a Patient Treated with Dabigatran Etexilate

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 5, May 2012, Pages: e103–e107, Cassie A. Barton, Wesley D. McMillian, S. Sadi Raza and Ray E. Keller

    Version of Record online : 9 APR 2012, DOI: 10.1002/j.1875-9114.2012.01036.x

  16. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1411–1419, Dr Joachim Stangier, Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth and Dr Kasra Shakeri-Nejad

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008324179

  17. You have free access to this content
    A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue 1, January 2005, Pages: 103–111, B. I. ERIKSSON, O. E. DAHL, H. R. BÜLLER, R. HETTIARACHCHI, N. ROSENCHER, M-L. BRAVO, L. AHNFELT, F. PIOVELLA, J. STANGIER, P. KÄLEBO, P. REILLY and FOR THE BISTRO II STUDY GROUP

    Version of Record online : 22 DEC 2004, DOI: 10.1111/j.1538-7836.2004.01100.x

  18. You have free access to this content
    Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 11, November 2007, Pages: 2178–2185, B. I. ERIKSSON, O. E. DAHL, N. ROSENCHER, A. A. KURTH, C. N. VAN DIJK, S. P. FROSTICK, P. KÄLEBO, A. V. CHRISTIANSEN, S. HANTEL, R. HETTIARACHCHI, J. SCHNEE, H. R. BÜLLER and FOR THE RE-MODEL STUDY GROUP

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1538-7836.2007.02748.x

  19. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  20. You have free access to this content
    S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 7, July 2011, Pages: 1375–1382, A. RUPIN, I. MARX, M. O. VALLEZ, P. MENNECIER, P. GLOANEC, G. DE NANTEUIL and T. J. VERBEUREN

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1538-7836.2011.04286.x